A suggestion for the prevention of severe clinical forms of schistosomiasis mansoni.
作者信息
Kloetzel K
出版信息
Bull World Health Organ. 1967;37(4):686-7.
Abstract
摘要
相似文献
1
A suggestion for the prevention of severe clinical forms of schistosomiasis mansoni.关于预防曼氏血吸虫病严重临床类型的一项建议。
Bull World Health Organ. 1967;37(4):686-7.
2
Treatment of schistosomiasis mansoni with antimony-omega, omega-dimercapto-potassium succinate (TWSb).
Am J Trop Med Hyg. 1954 Jul;3(4):714-27. doi: 10.4269/ajtmh.1954.3.714.
3
Present status of the treatment of schistosomiasis mansoni.曼氏血吸虫病的治疗现状
Rev Inst Med Trop Sao Paulo. 1969 Sep-Oct;11(5):363-76.
4
[Therapeutic evaluation of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].二巯基丁二酸钠与锑剂治疗曼氏血吸虫病的疗效评价
Rev Bras Med. 1967 Feb;24(2):97-9.
5
[Intensive treatment of schistosomiasis].[血吸虫病的强化治疗]
Rev Med Moyen Orient. 1954 Jan-Mar;11(1):89-92.
6
Triostam in schistosomiasis.
Trans R Soc Trop Med Hyg. 1954 Jul;48(4):351-2. doi: 10.1016/0035-9203(54)90109-1.
7
[Sodium antimony III gluconate in the treatment of schistosomiasis mansoni].葡萄糖酸锑钠治疗曼氏血吸虫病
Rev Assoc Med Bras. 1957 May;3(1):33-6.
8
Recent advances in vaccine research against schistosomiasis in Brazil.巴西血吸虫病疫苗研究的最新进展
Acta Trop. 2008 Nov-Dec;108(2-3):256-62. doi: 10.1016/j.actatropica.2008.05.023. Epub 2008 Jun 5.
9
[Clinical aspects of bilharziasis].[血吸虫病的临床方面]
Z Gesamte Inn Med. 1969 Dec 1;24(23):833-40.
10
[Therapeutic use of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].二巯基丁二酸钠锑络合物治疗曼氏血吸虫病的疗效观察
Hospital (Rio J). 1965 Dec;68(6):1361-75.
引用本文的文献
1
Prior infection protects against induced hepatic fibrosis.既往感染可预防诱导性肝纤维化。
Front Vet Sci. 2024 Oct 8;11:1443267. doi: 10.3389/fvets.2024.1443267. eCollection 2024.
2
In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against Infection in Preclinical Murine Models.体内评价载吡喹酮固体脂质纳米粒对临床前鼠模型感染的作用。
Int J Mol Sci. 2022 Aug 22;23(16):9485. doi: 10.3390/ijms23169485.
3
In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention.用于血吸虫病干预的抗体功能化脂质纳米系统的体内评价
Pharmaceutics. 2022 Jul 22;14(8):1531. doi: 10.3390/pharmaceutics14081531.
4
Ginger (Zingiber Officinale)-derived nanoparticles in Schistosoma mansoni infected mice: Hepatoprotective and enhancer of etiological treatment.姜（Zingiber officinale）衍生纳米颗粒对感染曼氏血吸虫的小鼠的保护作用：对病因治疗的增强作用。
PLoS Negl Trop Dis. 2021 May 20;15(5):e0009423. doi: 10.1371/journal.pntd.0009423. eCollection 2021 May.
5
6
Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.9-(S)-[3-羟基-2-(膦酰甲氧基)丙基]腺嘌呤对小鼠曼氏血吸虫病的活性。
Antimicrob Agents Chemother. 2003 Dec;47(12):3853-8. doi: 10.1128/AAC.47.12.3853-3858.2003.
本文引用的文献
1
Splenomegaly in schistosomiasis mansoni.曼氏血吸虫病中的脾肿大。
Am J Trop Med Hyg. 1962 Jul;11:472-6. doi: 10.4269/ajtmh.1962.11.472.
2
SOME QUANTITATIVE ASPECTS OF DIAGNOSIS AND EPIDEMIOLOGY IN SCHISTOSOMIASIS MANSONI.曼氏血吸虫病诊断与流行病学的一些定量方面
Am J Trop Med Hyg. 1963 May;12:334-7. doi: 10.4269/ajtmh.1963.12.334.
3
[On the advantage of chemotherapy of schistosomiasis in a population in continuous contact with the foci. (Preliminary note)].[关于在持续接触疫源地的人群中进行血吸虫病化疗的优势（初步报告）]
Rev Inst Med Trop Sao Paulo. 1963 Mar-Apr;5:106-10.
Zotero 插件